The new findings, recently published in Nature Medicine, may help guide optimal treatment for MIS-C.

Friday, February 18, 2022 NIH Scientists Advance Understanding of Pediatric Immune Responses to COVID-19 and Rare Inflammatory Syndrome A comprehensive analysis evaluating immune responses in children with COVID-19 and in those with a rare post-infection inflammatory syndrome called MIS-C has revealed distinct immunopathological signatures associated with each condition. The new findings, recently published in Nature Medicine, may help guide optimal treatment for MIS-C (multisystem inflammatory syndrome in children). Read more on the NIAID Now Blog: National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107